1
Unmilola OM, Taiwo LO: Experience of menopausal symptoms by women in an urban community in Ibadan, Nigeria. Menopause 2008, 16:1?. 5. R str K, Bengtsson C, Lissner L, Milsom I, Sundh V, Bj kelund C: A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002, 9:156?61. 6. National Institutes of Health state of sci
1
Unmilola OM, Taiwo LO: Experience of menopausal symptoms by women in an urban community in Ibadan, Nigeria. Menopause 2008, 16:1?. 5. R str K, Bengtsson C, Lissner L, Milsom I, Sundh V, Bj kelund C: A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002, 9:156?61. 6. National Institutes of Health state of sci
1
Unmilola OM, Taiwo LO: Experience of menopausal symptoms by women in an urban community in Ibadan, Nigeria. Menopause 2008, 16:1?. 5. R str K, Bengtsson C, Lissner L, Milsom I, Sundh V, Bj kelund C: A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002, 9:156?61. 6. National Institutes of Health state of sci
1
The impacts of economic and drought/smoke crises on infant mortality and birth weight in Indonesia. Michiagan: Michigan State University; 2003.doi:10.1186/1471-244X-14-81 Cite this article as: Ho et al.: Impact of 2013 south Asian haze crisis: study of physical and psychological symptoms and perceived dangerousness of pollution level. BMC Psychiatry 2014 14:81.Submit your next manuscript to BioMed
1
F survey. FP prepared the protocol and sought ethics approval from Shandong University. CSH performed the literature review and wrote the introduction. YL and RCMH performed the statistical analysis and designed data presentation. All authors read and approved the final manuscript.Ho et al. BMC Psychiatry 2014, 14:81 http://www.biomedcentral.com/1471-244X/14/Page 8 ofAuthor details 1 Southeast Asi
1
Ed in participating in a randomised trial, of which 4295 women were found to be eligible according to the preliminary assessment. The eligibility criteria included age of 50 to 64 and an elapsed time of 12 months or more since the last period at the randomisation stage [21]. A personal invitation was mailed to eligible women in 1999?001. A total of 2323 women responded to the invitation to visit t
1
Fferent surveys using the date of filling in the questionnaire. We then grouped the surveys as follows: 6?8 months = 1-year follow-up, 19?8 months = 2-year follow-up, 29?2 months = 3year follow-up, 43?9 months =4-year follow-up. Women who left one or more follow-up surveys unanswered formed a separate group (intermittent surveys). We classified women into those who had or had not had symptoms in t
1
E therapy to either placebo or nothing (the control groups) [21]. Women were recruited in Estonia from 1999?001, and followed by annually mailed questionnaires in 2000?004. Detailed descriptions of the recruitment, inclusion and exclusion criteria, trial treatment, adherence, follow-up and trial outcomes as well as the content of information leaflets and trial questionnaires have been published el